Get started
Author

Merve Başar

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
2025 · Carissa E. Chu, Ziyu Chen, et al. · European Urology · 27
Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer
2024 · Sakina A. Plumber, Tiffany Tate, et al. · Nature Communications · 22
PDF
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
2024 · Dilara Akbulut, Karissa Whiting, et al. · Modern Pathology · 21
PDF
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy
2026 · Zeda Zhang, Yu-Jui Ho, et al. · Cell · 12
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer
2025 · Kevin Chang, Henry M. Delavan, et al. · Nature Communications · 10
PDF
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer
2025 · Ziyu Chen, Xinran Tang, et al. · Nature Communications · 8
Abstract 4632: Lineage plasticity as a determinant of antibody-drug conjugate target expression in urothelial bladder cancer
2024 · Jiaqian Luo, Sizhi P. Gao, et al. · Cancer Research · 8
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract
2025 · Rayan Rammal, Florestan J. Koll, et al. · Modern Pathology · 6
Micropapillary Urothelial Carcinoma: A Review and Update
2026 · Merve Basar, Cansu Yol, et al. · Advances in Anatomic Pathology · 2
PTK-7 Expression in Gastric Cancer: A Prognostic Determinant
2019 · Melike Özçelik, Özlem Ercelep, et al. · Balkan Medical Journal · 2
PDF
Profile of head and neck cancers in dr. lütfi kırdar kartal educational and research hospital
2015 · Kayhan Basak, Yasin Saglam, et al. · Turkish Journal of Pathology · 2
PDF
Membranous and cytoplasmic Nectin4 expression and outcomes with enfortumab vedotin plus pembrolizumab in metastatic urothelial carcinoma.
2026 · Michal Sternschuss, Karissa Whiting, et al. · Journal of Clinical Oncology · 1
Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non–Muscle-Invasive Bladder Cancer
2026 · Andrew B. Katims, Charlie White, et al. · Clinical Cancer Research · 1
Ip14-11 Characterization of the Immune Landscape of Bladder Cancer With Variant Histology
2025 · Ao Zhang, Fengshen Kuo, et al. · The Journal of Urology · 1
Abstract PR005: Final results from a Phase I trial of intravesical chemoimmunotherapy with gemcitabine and Bacillus Calmette-Guérin (BCG) for patients with BCG-exposed high-grade non-muscle invasive bladder cancer
2024 · Syed M. Alam, Christopher D. Gaffney, et al. · Clinical Cancer Research · 1
Profile of Head and Neck Cancers In Dr. Lütfi kirdar Kartal Research and Training Hospital: Pathology Report Based Study
2015 · Kayhan Başak, Yasin Sağlam, et al. · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · 1
Comprehensive clinical and genomic analysis of early-onset cancer of the bladder and upper urinary tract
2026 · Hong Truong, Jordan Eichholz, et al. · JNCI Journal of the National Cancer Institute
Paired Nectin4 expression analysis pre and post enfortumab vedotin and pembrolizumab in urothelial carcinoma.
2026 · Michal Sternschuss, Karissa Whiting, et al. · Journal of Clinical Oncology
Ip36-04 Integrative Clinical and Molecular Characterization of Metastasis and Resistance to Antibody-drug Conjugates in Sarcomatoid Variant Bladder Cancer
2026 · Jiaqian Luo, Sizhi P. Gao, et al. · The Journal of Urology
Ip47-11 Leveraging Patient Derived Organoids to Model Urothelial Carcinoma With Aberrant Histology
2026 · Ao Zhang, Merve Basar, et al. · The Journal of Urology
Abstract LB191: Decoding metastasis and therapy resistance in sarcomatoid bladder cancer
2026 · Jiaqian Luo, Sizhi P. Gao, et al. · Cancer Research
Abstract 4036: Deciphering regulatory drivers of lineage plasticity and resistance to antibody-drug conjugates in urothelial bladder cancer
2026 · Jiaqian Luo, Sizhi P. Gao, et al. · Cancer Research
Abstract 4757: CREBBP drives tumorigenicity via aberrant IL-1α signaling in EP300 altered bladder cancer
2026 · James August Rodrigues, Hikmat A. Al-Ahmadie, et al. · Cancer Research
HER2 and nectin-4 IHC expression and clinical outcomes with enfortumab vedotin plus pembrolizumab in metastatic urothelial carcinoma.
2026 · David H. Aggen, Michal Sternschuss, et al. · Journal of Clinical Oncology
PDF
768 Expression of Antibody-Drug Conjugate Targets on Neuroendocrine Carcinoma of the Bladder, and Association with Novel Neuroendocrine Markers
2026 · Dilara Akbulut, Merve Basar, et al. · Laboratory Investigation
Works count: 37
Citation count: 125
H-index: 7
I10-index: 5
Year
Topic
Type